Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 10 holding rows worth $163,149,229.

Accession
0001193125-26-225480
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 10 entries on the cover page, a total value of $163,149,229 stated on the cover page (in dollars after the unit check, H1), rows summing to $163,149,231 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BICARA THERAPEUTICS INC055477103COM2,392,150$47,579,864dollars as filed
NUVATION BIO INC COM CL A67080N101Stock8,081,089$34,667,872dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW3,289,661$29,442,466dollars as filed
KESTRA MED TECHNOLOGIES LTDG52441105SHS1,022,149$20,371,430dollars as filed
BETA BIONICS INC08659B102COMMON STOCK1,316,183$13,188,154dollars as filed
ENGENE HOLDINGS INC29286M105COM876,357$5,967,991dollars as filed
ALUMIS INC022307102COM241,255$5,314,848dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$2,430,000dollars as filed
IMAGENEBIO INC45175G207CMN455,361$2,276,805dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK248,672$1,909,801dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-225480this filing2026-05-15acceptance time not in the bulk data set